Cell signaling is a term used to describe a complex interactive system of signals that act to regulate or mediate a cellular response. Therapies that target cell signaling pathways have the potential to effectively reverse molecular deregulation underlying disease. The inherent complexity of cell signaling presents a major challenge to designing such therapies however, because perturbation of pathways has the potential to produce dramatic adverse effects. Pathologists are in the primary position of detecting adverse responses in drug development and are essential members of teams whose goal is to determine the mechanisms underlying tissue responses. The pathologist therefore will be expected to integrate morphologic interpretation with data obtained from several laboratory-based methods and data derived from novel technologies. Approaches being used include several in silico tools that provide access to public databases and signal pathway visualization that can serve to focus on key mechanistic hypotheses. The main objective of this article is to discuss a basic mechanistic approach and methods that can be used to associate modulation of cell signaling pathways with pathologic endpoints. The approach suggested begins with diagnostic pathology and uses global gene expression analysis in conjunction with transcription factor profiling and confirmatory protein technologies, to elucidate pathways relevant to the biological mechanism. Another important objective is to highlight the use of in silico technologies to prioritize laboratory efforts and focus these efforts on key hypotheses.
WHAT IS CELL SIGNALING? The term "cell signaling" describes complex interactive systems that act to regulate or mediate a cellular process. The most commonly measured output of these signaling cascades is gene transcription and posttranslational modification of protein, with the ultimate goal being to induce a cellular response. The ultimate goal of cell signaling is conceptually important to keep in mind because as the numbers of cell signaling factors continues to grow, the numbers of responses available to cells have been defined. Infact, it is the apparent funneling of a wide variety of cell signaling pathways into a defined number of cellular responses that raises the importance of the pathological observation to the most critical first step in an investigative journey to define mechanisms.
Initial mechanistic hypotheses can be formulated by harvesting knowledge about the pathways that regulate the cellular responses in a pathological lesion. For example, the observation of numerous mitotic figures and apoptotic bodies in a hyperplastic lesion following a chemical exposure might lead one to review what is currently known about regulation of this endpoint, prompting a search for signaling pathways regulating apoptosis and mitosis. In this regard, signaling pathways such WNT, Mitogen activated protein kinases (MAPK), or p53 may evolve as candidate pathways. Subsequently, this search can also be narrowed by focusing initially on what is expected from the chemical entity (e.g., known mechanisms of action, protein binding, inhibitory activities etc) and what pathways are avialable in the target tissue.
THE EXPERIMENTAL APPROACH
The experimental approach (Figure 1) closely follows the idea that starting with a global approach using microarray technology and then connecting transcription factor activation profiles to pathways responsible for regulating their phosphorylation will connect back to the cellular trigger. Analysis of gene expression profiles can be used as a first step in generating hypotheses about pathway regulation. Gene expression microarray technology has been extensively reviewed elsewhere (Butte, 2002; Chuaqui et al., 2002; Valafar, 2002; Hatfield et al., 2003) . In general, expression analysis will yield a list of genes whose mRNA are up-or downregulated in the target cell population or tissue in response to insult or exposure. Gene expression can thereby provide a snapshot of relative mRNA abundance at the time of measurement. Since one goal of cell signaling pathway regulation is to regulate expression of mRNA and the primary targets of many chemical entities are the proteins within these pathways, gene expression profiles can provide fingerprints of pathway modulation.
The first application of in silico or computer based tools in the experimental approach proposed is visualization of gene profiles. In silico analytical visualization is an effective way to highlight useful expression patterns. Detailed information about popular visualization and analysis tools Genesis and Spotfire have been reviewed elsewhere (Asher, 2000) . The Spotfire DecisionSite for Functional Genomics is a guided analytical visualization environment with several applications in addition to microarray data visualization and analysis ( http://www.spotfire.com/images/pdf/sci.pdf ; http:// www.bio-itworld.com/news/060203 report2590.html ). The actual choice of visualization tool will depend on several factors not the least of which will be user interface, output, presentation and ease of use, and analytical features.
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TOXICOLOGIC PATHOLOGY FIGURE 1.-Suggested experimental approach to connect signaling pathways with pathological endpoints. The experimental approach closely follows the idea that beginning with the cellular response and by connecting gene expression, transcription factors to the pathways responsible for regulating them, information can be gained about the mechanism. DEVELOPING HYPOTHESES ABOUT PATHWAYS FROM GENE DATA Regulation of gene expression largely depends on recognition of specific promoter sequences by transcriptional regulatory proteins (Lee and Young, 2000; Garvie and Wolberger, 2001; Cheng et al., 2002; Orphanides and Reinberg, 2002) . Following posttranslational modification, transcription factors recruit and regulate chromatin-modifying complexes and components of the transcription apparatus. In silico tools that provide methods for genome-wide binding analysis (also known as genome-wide location analysis), enable investigators to identify the set of target genes bound in vivo by each of the transcriptional regulators. This profiling approach represents a key next step in elucidating regulatory pathways modulated by a chemical entity. Applied to microarray data, a list of genes can be clustered by transcription factor binding sites and essentially connected to pathways that may regulate binding of these factors to regulatory sites in the promoter region of genes. From this analysis, regulatory networks may emerge. There are several tools being developed and are available for promoter region analysis. Of these, this author is most familiar with EZ retrieve-Sequence retrieval and search engine for transcription factor binding sites, TRANSFAC (database of transcription factor binding sites) and MatInspector (Quandt et al., 1995; Wingender et al., 2000; Jegga et al., 2002; Zhang et al., 2002) .
Tools used to identify transcription factor binding sites will search for highly correlated sequence fragments versus transcription factor binding sites in a transcription factor profile database using the general scheme shown in Figure 2 . It is important for the software tool to provide an interface for retrieval of sequences in the promoter region of genes of interest. EZ retrieve uses a Human, Mouse, Rat Genes Draft Sequence Retrieve Tool: based on NCBI data model (ASN.1 file), to query UniGene and Locuslink to retrieve any particular region (upstream or downstream relative to the transcription start site) of genes of interest (Zhang et al., 2002) . This interface allows the user to input UniGene ID, GenBank ID, and I.M.A.G.E clone ID to retrieve the sequence of interest. Promoter sequences for specific cDNAs can also be obtained from genomic sequences by exon mapping. Promoter prediction tools can then be used to locate promoters directly in the genomic sequence. Once sufficient numbers of promoter sequences have been obtained, comparative promoter FIGURE 2.-Typical scheme for promoter region analysis. The scheme represents a typical gene promoter region analysis.
Step 1 is usually retrieval of sequence proximal to the transcription start site, followed by an analysis of this region for sequences corresponding to transcription factor binding sites. analysis of coregulated genes and groups of genes can be used to generate models predicting regulatory pathways for those genes. This approach can also be used to identify promoter modules responsible for the common regulation of promoters solely by the application of bioinformatics methods. Such modules represent the molecular mechanisms through which regulatory networks influence gene expression. An important advantage of this approach is that it does not depend on elucidating or linking functional features of genes without detectable sequence similarity, but instead links genes on the basis of their common promoter regions and have predicted coregulation.
PATHWAY VISUALIZATION
Pathway building and visualization is key to understanding and generating testable hypotheses about complex regulatory interactions of signaling. As expected, this area also represents an active area for a variety of commercial venders and public database providers. There are several tools available, but the 2 that we have the most experience with are discussed here. TRANSPATH is a database system of gene regulatory networks that combines information on signal transduction with tools for visualization and analysis (Krull et al., 2003) ; More information on TRANSPATH is also available at http://www.biobase.de/pages/products/databases.html . One of the major tools developed for Science's signal transduction knowledge environment is the Connections Map database and the software [acronym, CMADES (Gough)] created to facilitate data entry by Pathway Authorities. The Connections Maps are a graphical representation of a database of information about the molecules involved in cellular signaling cascades (Gough, 2002) .
A personal favorite is PathwayAssist, a program that uses proprietary graph visualization to represent biological pathways, gene regulation networks and protein-protein interaction maps for exploration and prediction http://www. ariadnegenomics.com/products/pathway.html . The software can handle a variety of tasks, but most importantly Path-wayAssist is the user-interface for the knowledge database generated by MedScan and a number of public sources. The pathway database in PathwayAssist was compiled from PubMed abstracts allowing access to information about regulation, interaction and modification that can be validated by reading the literature from which the information was derived. PathwayAssist and similar software tools represent the most powerful means for harvesting biological information and pathway building to date. The result of the effort will be a defined set of potential pathways and regulatory molecules that will be the foundation for focused wet-lab experiments to test hypotheses.
TESTING HYPOTHESES: OBTAINING EVIDENCE
OF PATHWAY ACTIVATION The laboratory technologies chosen to obtain evidence of pathway modulation by a chemical entity will depend on the questions asked. The scope of this paper is limited to a short list of technologies (transcription factor profiling, tissue arrays, laser capture microdissection/mass spectrometry, multiplex western analysis) that have proven to be valuable tools in problem solving around signal transduction and pathway regulation. In general, measuring defined regulatory components of pathways are the single best source for confirmation of pathway modulation.
Transcription Factor Profiling
Signal regulated transcription factors are critical for stimulation of gene expression because they are responsible for recruitment of coactivators to specific DNA binding sites. Transcription factors regulate gene expression via 2 distinct domains; one that displays high affinity for a specific DNA sequence and one that confers transcriptional activity. Transcription factors are activated by phosphorylation of specific residues or by processing bound inhibitory proteins. The terminal kinases (those most distal to a membrane signal and closest to transcription factor regulation) in most signaling cascades activate transcription factors via phosphorylation of specific residues and this phosphorylation event is critical for transcription factor's role in regulation of gene expression. Transcription factor phosphorylation patterns therefore represent a critical mechanistic connection between mRNA profiling and signaling pathway modulation.
The electrophoretic mobility shift assay (EMSA) is the most widely used method for measuring transcription factor binding activity (Kerr, 1995) . The gel-shift assay is a, sensitive, technically straight forward and widely used method 134 DAVIS TOXICOLOGIC PATHOLOGY for investigating nucleic acid-protein interaction. The assay is based on the observation that binding of protein to DNA or RNA fragments usually leads to a reduction in the electrophoretic mobility of the fragment in non-denaturing gels. EMSA can also be time-consuming and in most labs, does not allow for high-throughput analysis. ELISA-based transcription factor profiling assays are rapid and amenable to a high-throughput format that enables simultaneous screening of up to 96 samples. Several transcription factor profiling kits are commercially available. Most of these ELISA-type assays are equal in sensitivity to classic gel shift assays. (BD Mercury TransFactor Kits and BD Mercury TransFactor Profiling plates; Active Motif's TransAM kits).
Tissue Arrays
Multiple tissue arrays allow for high throughput screening by immunohistochemistry and in-situ hybridization. Tissue arrays are useful for a variety of applications including protein expression studies, protein translocation, antibody screening, tissue-type specificity studies, and animal model analyses (Torhorst et al., 2001; Terris and Bralet, 2002) . For a recent and comprehensive review of this technology see Skacel et al. (2002) . A good example of the application of tissue arrays to pathway regulation can be found in Xie, W., et al. (2002) whose investigation used tissue arrays to examine Smad signaling.
Laser Capture Microdissection/Mass Spectrometry
One of the key end points for elucidating mechanism is the measurement of signaling in specific cell populations within lesions. Microdissection techniques allow precise extraction of morphologically distinct cells for isolation of proteins. Laser capture microdissection (LCM) utilizes an infrared laser integrated into a standard microscope (Suarez-Quian et al., 1999) . LCM, coupled with downstream proteomics applications, such as 2-or 1-dimensional polyacrylamide gel electrophoresis and mass spectrometry (MS) analysis, may facilitate the characterization and identification of protein expression changes that distinguish pathway regulation in normal and affected cell populations. Recently, it was demonstrated that cells obtained by LCM can be directly analyzed by matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS; (Xu et al., 2002) . The combined technology of Surface-enhanced laser desorption/ionization mass spectrometry (SELDI) and LCM is an effective means to distinguish protein expression patterns between normal and abnormal cell populations.
Multiplex Western Analysis
Western blot analysis is one of the most useful rapid screening tools for protein quantitation and measurement of protein modifications. Phosphorylation/dephosphorylation of kinases and adaptor proteins represents the most common posttranslational modification partially responsible for pathway regulation in the cell. From 1990 to present, numerous siteand phosphorylation state-specific antibodies have been developed and many are commercially available. Through the use of phosphospecific antibodies, a profile of kinase pathway regulation can be obtained by Western blot analysis. One lim-FIGURE 3.-Example of a multiplex western analysis. A single well gel is used to separate 500-1,000 µg of protein extract derived from NRK-52 E cells in culture. The protein was then transferred to a PVDF membrane, blocked with 5.0% nonfat milk in TBS-Tween. The membrane was then placed in a BioRad Mini-PROTEAN II multiscreen apparatus and incubated with several primary antibodies, washed, and then incubated with appropriate HRP-conjugated secondary detection antibodies. The detection system used was the Pierce Super Signal. A resulting detected protein is shown.
itation of western analysis has been the numbers of proteins that can be assayed per sample. This limitation can be overcome by multiplexing techniques such as utilizing the Mini-PROTEAN R II multiscreen apparatus (BioRad) that offers the user the ability to screen a western blot with up to 40 different antibodies simultaneously (Figure 3) . For those wishing to outsource multiplex western screening, BD PowerBlot offered by BD Biosciences/Pharmingen and Kinetworks protein kinase screens from Kinexus Bioinformatics Corporation are unique protein screening services based on this concept.
Protein arrays are another promising technology that has the potential to measure a diverse range of protein interactions. Antibody arrays are a specific subset of this technology. The process of arraying multiple antibodies on a solid surface are now used in a wide variety of applications. Indeed, antibody arrays have proven to be dynamic in response to a broad range of possible applications. A discussion of variations in antibody array design and current and potential applications of this novel and interesting technology can be found in a recent review (Lal et al., 2002) .
CONCLUSIONS
The main goal of this manuscript was to introduce a laboratory approach that begins with the pathological diagnosis and can be used to elucidate mechanisms of chemical induced modulation of signaling pathways. The approach and most of the technology presented is expected to be of considerable interest to pathologists since the microscopic characterization of a tissue response/disease process is a critical initial step for a research team dedicated to understanding etiology and mechanism. Although the choice of scientific approach applied to mechanistic studies will vary, application of technologies that exploit the use of the affected tissue and the expertise of the pathologist are likely to yield unique scientific insight.
